Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.80
Delayed Data
As of Jul 21
 -0.01 / -0.36%
Today’s Change
1.81
Today|||52-Week Range
3.15
+35.27%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close2.81
Today’s open2.86
Day’s range2.79 - 2.88
Volume804,971
Average volume (3 months)1,609,439
Market cap$445.7M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc+0.02+0.40%
BCRXBioCryst Pharmaceuti...-0.16-2.87%
JNCEJounce Therapeutics ...+0.02+0.15%
ATRAAtara Biotherapeutic...+0.10+0.63%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts